147 related articles for article (PubMed ID: 18493977)
1. Mesenchymal stem cells for graft-versus-host disease: close encounters with T cells.
Dazzi F; Marelli-Berg FM
Eur J Immunol; 2008 Jun; 38(6):1479-82. PubMed ID: 18493977
[TBL] [Abstract][Full Text] [Related]
2. IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease.
Polchert D; Sobinsky J; Douglas G; Kidd M; Moadsiri A; Reina E; Genrich K; Mehrotra S; Setty S; Smith B; Bartholomew A
Eur J Immunol; 2008 Jun; 38(6):1745-55. PubMed ID: 18493986
[TBL] [Abstract][Full Text] [Related]
3. Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in mice.
Jang MJ; Kim HS; Lee HG; Kim GJ; Jeon HG; Shin HS; Chang SK; Hur GH; Chong SY; Oh D; Chung HM
Acta Haematol; 2013; 129(4):197-206. PubMed ID: 23257958
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation.
Zhao K; Lou R; Huang F; Peng Y; Jiang Z; Huang K; Wu X; Zhang Y; Fan Z; Zhou H; Liu C; Xiao Y; Sun J; Li Y; Xiang P; Liu Q
Biol Blood Marrow Transplant; 2015 Jan; 21(1):97-104. PubMed ID: 25300866
[TBL] [Abstract][Full Text] [Related]
5. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal Stromal Cell (MSC)-Derived Combination of CXCL5 and Anti-CCL24 Is Synergistic and Superior to MSC and Cyclosporine for the Treatment of Graft-versus-Host Disease.
Fan X; Guo D; Cheung AMS; Poon ZY; Yap CS; Goh SE; Guo D; Li H; Bari S; Li S; Lim KH; Hwang WYK
Biol Blood Marrow Transplant; 2018 Oct; 24(10):1971-1980. PubMed ID: 29883796
[TBL] [Abstract][Full Text] [Related]
7. Treatment of graft-versus-host-disease with mesenchymal stromal cells.
Kebriaei P; Robinson S
Cytotherapy; 2011 Mar; 13(3):262-8. PubMed ID: 21231805
[TBL] [Abstract][Full Text] [Related]
8. Co-infusion of donor bone marrow with host mesenchymal stem cells treats GVHD and promotes vascularized skin allograft survival in rats.
Aksu AE; Horibe E; Sacks J; Ikeguchi R; Breitinger J; Scozio M; Unadkat J; Feili-Hariri M
Clin Immunol; 2008 Jun; 127(3):348-58. PubMed ID: 18387852
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stromal cells inhibit graft-versus-host disease of mice in a dose-dependent manner.
Joo SY; Cho KA; Jung YJ; Kim HS; Park SY; Choi YB; Hong KM; Woo SY; Seoh JY; Cho SJ; Ryu KH
Cytotherapy; 2010 May; 12(3):361-70. PubMed ID: 20078382
[TBL] [Abstract][Full Text] [Related]
10. [Research progress on immunologic mechanisms of mesenchymal stem cells for treatment of graft-versus-host disease].
Wang RP; Chen H; Guo YQ; Wu RN; Zhang B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):550-3. PubMed ID: 21518528
[TBL] [Abstract][Full Text] [Related]
11. Effects of bone marrow mesenchymal stem cells on hematopoietic recovery and acute graft-versus-host disease in murine allogeneic umbilical cord blood transplantation model.
Li ZY; Wang CQ; Lu G; Pan XY; Xu KL
Cell Biochem Biophys; 2014 Sep; 70(1):115-22. PubMed ID: 24696072
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells of cord blood origin are effective at preventing but not treating graft-versus-host disease.
Tisato V; Naresh K; Girdlestone J; Navarrete C; Dazzi F
Leukemia; 2007 Sep; 21(9):1992-9. PubMed ID: 17625609
[TBL] [Abstract][Full Text] [Related]
13. Unraveling mechanisms of mesenchymal stromal cell-mediated immunomodulation through patient monitoring and product characterization.
Schepers K; Fibbe WE
Ann N Y Acad Sci; 2016 Apr; 1370(1):15-23. PubMed ID: 26713608
[TBL] [Abstract][Full Text] [Related]
14. The immunosuppressive properties of non-cultured dermal-derived mesenchymal stromal cells and the control of graft-versus-host disease.
Gao L; Liu F; Tan L; Liu T; Chen Z; Shi C
Biomaterials; 2014 Apr; 35(11):3582-8. PubMed ID: 24468404
[TBL] [Abstract][Full Text] [Related]
15. Reduced efficacy of mesenchymal stromal cells in preventing graft-versus-host disease in an in vivo model of haploidentical bone marrow transplant with leukemia.
Oviedo A; Yañez R; Colmenero I; Aldea M; Rubio A; Bueren JA; Lamana ML
Cell Transplant; 2013; 22(8):1381-94. PubMed ID: 23044223
[TBL] [Abstract][Full Text] [Related]
16. Sequential third-party mesenchymal stromal cell therapy for refractory acute graft-versus-host disease.
Sánchez-Guijo F; Caballero-Velázquez T; López-Villar O; Redondo A; Parody R; Martínez C; Olavarría E; Andreu E; Prósper F; Díez-Campelo M; Regidor C; Villaron E; López-Corral L; Caballero D; Cañizo MC; Pérez-Simon JA
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1580-5. PubMed ID: 24952358
[TBL] [Abstract][Full Text] [Related]
17. A novel study on the immunomodulatory effect of umbilical cord derived mesenchymal stem cells pretreated with traditional Chinese medicine Asarinin.
He H; Yang T; Li F; Zhang L; Ling X
Int Immunopharmacol; 2021 Nov; 100():108054. PubMed ID: 34492537
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of bone marrow-derived mesenchymal stem cells in the treatment of sclerodermatous chronic graft-versus-host disease: clinical report.
Zhou H; Guo M; Bian C; Sun Z; Yang Z; Zeng Y; Ai H; Zhao RC
Biol Blood Marrow Transplant; 2010 Mar; 16(3):403-12. PubMed ID: 19925878
[TBL] [Abstract][Full Text] [Related]
19. Features of synergism between mesenchymal stem cells and immunosuppressive drugs in a murine heart transplantation model.
Eggenhofer E; Renner P; Soeder Y; Popp FC; Hoogduijn MJ; Geissler EK; Schlitt HJ; Dahlke MH
Transpl Immunol; 2011 Sep; 25(2-3):141-7. PubMed ID: 21704160
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy of cord blood-derived mesenchymal stromal cells for the prevention of acute graft-versus-host disease in a xenogenic mouse model.
Gregoire-Gauthier J; Selleri S; Fontaine F; Dieng MM; Patey N; Despars G; Beauséjour CM; Haddad E
Stem Cells Dev; 2012 Jul; 21(10):1616-26. PubMed ID: 21910645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
